EGFR and non-small cell lung carcinoma: Mutations in the Erb-1 gene encoding EGFR are present in 10–20% of patients developing squamous cell lung cancer and rearrangements of the ALK gene are present in around 3.2% of patients developing non-small cell lung cancer (NSCLC) [3, 4].